Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Blanco

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Annals of the New York Academy of Sciences|November 23, 2006
Rickettsia slovaca infection: DEBONEL/TIBOLAV Ibarra, J A Oteo, A Portillo, et al.
Annals of the New York Academy of Sciences|November 23, 2006
Prevalence of spotted fever group Rickettsia species detected in ticks in La Rioja, SpainJ A Oteo, A Portillo, S Santibáñez, et al.
HIV Medicine|December 31, 2019
Retinol-binding protein 4 (RBP4), a potential biomarker of frailty in HIV-infected people on stable antiretroviral therapyJ-R Blanco, L Romero, E Ramalle-Gómara, et al.
HIV Medicine|March 4, 2016
Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapyV Estrada, S Monge, M D Gómez-Garre, et al.
Epidemiology and Infection|November 6, 2001
Presence of granulocytic ehrlichia in ticks and serological evidence of human infection in La Rioja, SpainJ A Oteo, H Gil, M Barral, et al.
HIV Medicine|March 25, 2014
Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir-boosted protease inhibitor-based versus a nonnucleoside reverse transcriptase inhibitor-based first-line regimenI Jarrin, B Hernández-Novoa, B Alejos, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2015
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)S Monge, M Díez, M Alvarez, et al.
The Journal of Antimicrobial Chemotherapy|October 11, 2013
Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycinO Gasch, M Camoez, M A Domínguez, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 20, 2008
Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART statusS Moreno, I Jarrin, J A Iribarren, et al.
International Journal of Antimicrobial Agents|July 6, 2026
CABO-CHANCE study: A real-life world study of Cabotegravir plus Rilpivirine long-acting intramuscular in ART-experienced people with HIVC Hidalgo-Tenorio, M Aguilera García, I De Los Santos, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Annals of the New York Academy of Sciences|November 23, 2006
Rickettsia slovaca infection: DEBONEL/TIBOLAV Ibarra, J A Oteo, A Portillo, et al.
Annals of the New York Academy of Sciences|November 23, 2006
Prevalence of spotted fever group Rickettsia species detected in ticks in La Rioja, SpainJ A Oteo, A Portillo, S Santibáñez, et al.
HIV Medicine|December 31, 2019
Retinol-binding protein 4 (RBP4), a potential biomarker of frailty in HIV-infected people on stable antiretroviral therapyJ-R Blanco, L Romero, E Ramalle-Gómara, et al.
HIV Medicine|March 4, 2016
Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapyV Estrada, S Monge, M D Gómez-Garre, et al.
Epidemiology and Infection|November 6, 2001
Presence of granulocytic ehrlichia in ticks and serological evidence of human infection in La Rioja, SpainJ A Oteo, H Gil, M Barral, et al.
HIV Medicine|March 25, 2014
Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir-boosted protease inhibitor-based versus a nonnucleoside reverse transcriptase inhibitor-based first-line regimenI Jarrin, B Hernández-Novoa, B Alejos, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2015
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)S Monge, M Díez, M Alvarez, et al.
The Journal of Antimicrobial Chemotherapy|October 11, 2013
Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycinO Gasch, M Camoez, M A Domínguez, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 20, 2008
Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART statusS Moreno, I Jarrin, J A Iribarren, et al.
International Journal of Antimicrobial Agents|July 6, 2026
CABO-CHANCE study: A real-life world study of Cabotegravir plus Rilpivirine long-acting intramuscular in ART-experienced people with HIVC Hidalgo-Tenorio, M Aguilera García, I De Los Santos, et al.
Pageof 8